What to know about TrumpRx, the Trump administration’s prescription drug platform Trump launched a website to highlight lower cash prices for some treatments By Elaine Chen, John Wilkerson, and Chelsea CirruzzoFeb. 5, 2026

https://www.statnews.com/2026/02/05/trumprx-what-to-know-drug-prices/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-_45fEFN_nj2zZ7F87XrSSzm9PrfkiPTm7KA0ScIZLeqkOh09gOIfvACVCh7-VtZpLB2LwJtmeNGoHUwAaWwNKneYWrVw&_hsmi=402324933&utm_content=402324933&utm_source=hs_email President Trump’s new platform aimed at lowering prescription drug prices launched yesterday, after months of fanfare. Will it actually affect affordability? Depends on who you ask. The website, which uses technology from health care company GoodRx, displays the cash prices — that is, the prices available when paying without insurance — for certain drugs. It will not sell medications directly, but direct people elsewhere. The direct-pay model has been gaining traction in the pharma industry for years, spurred in part by Eli Lilly and Novo Nordisk and their GLP-1 obesity drugs. But buying drugs directly may end up being more expensive than using insurance in the long run, drug pricing experts say. My colleagues have all of the TrumpRx details — the where, what, who, when, why, and how expensive GLP-1’s will be